Prior to joining Regeneron, she was chief business officer of Constellation Pharmaceuticals. Professor, Departments of Pediatrics, Molecular and Human Genetics, and Neurology and Neuroscience, Baylor College; Director, Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital. in computer engineering from Columbia University, his MBA from the McDonough School of Business at Georgetown University and his M.D. Ned Braunstein, M.D., joined Regeneron in 2009, and serves as executive vice president, regulatory affairs and global patient safety. Prior to his current role, he served as Regenerons vice president of financial planning, and prior to joining Regeneron, he was vice president of finance at Mojave Therapeutics, Inc. This recognition is possible thanks to our dedicated colleagues, cutting-edge work and a culture that promotes limitless possibilities. Senior Vice President, Commercial Scale Manufacturing and Manufacturing Technology. 46 Regeneron Pharmaceuticals average salary is $95,435, median salary is $87,381 with a salary range from $41,600 to $373,100. . Additional pay could include bonus, stock, commission, profit sharing or tips. Lynn Macdonald, Ph.D., joined Regeneron in 1999 and serves as senior vice president, research. , She received her B.A. Prior to joining Regeneron, Mr. Drosman worked at Pfizer for 12 years holding various positions of increasing responsibility in pharmacovigilance, quality assurance and regulatory strategy. Christina Chan joined Regeneron in 2021 and serves as senior vice president, corporate communications and citizenship, leading a multidisciplinary team responsible for external & internal communication, patient advocacy, corporate responsibility, ESG strategy & reporting, and social impact. Dr. Morton earned a B.S. From 1998 until 2004, he held various managerial positions in the health and life sciences practice at Accenture, Ltd., a management consulting business. Prior to that she was chief diversity officer for Dow Jones, including its flagship brand, The Wall Street Journal. Prior to joining Regeneron, he held senior leadership positions in drug safety assessment at Genentech and Bristol-Myers Squibb. Before that, she has led global marketing research, corporate strategy and DE&I efforts at Fortune 50 companies such as Prudential Financial, Johnson & Johnson and ACNielsen. Each salary is associated with a real job position. Feb 1, 2023 11:58am. Andrew Murphy, Ph.D., joined Regeneron in 1999 as director of genomics and bioinformatics and is now executive vice president of research. and MBA from Iona College. Benjamin Drosman joined Regeneron in 2010 and serves as senior vice president, global development quality & regulatory compliance. Dr. Bassler has previously served as the president of the American Society for Microbiology, as well as on the boards for the American Association for the Advancement of Science, the National Science Foundation and the American Academy of Microbiology. Se continui a visualizzare Smita Pillai joined Regeneron as our first chief diversity, equity and inclusion (DEI) officer in 2021. Zoran Berkovic joined Regeneron in 2017 and is senior vice president, financial planning & analysis, where he has grown the scope of the group and fostered a culture of accountability. from Cornell University and a J.D. From 2009 to 2019, Mr. Ryan served as a director of Citizens Financial Group, Inc. Dr. Schleifer founded the company in 1988 and has been a director and its president and chief executive officer since its inception. She was previously executive vice president, chief human resources ocer at Inova Health System. Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. The top 10% of employees earn more than $139k per year. Mr. Fenimore holds an M.A. Lamentamos Regeneron employees attributed a compensation and benefits rating of 4.2/5 stars to their company. He received his Ph.D. in medicine and molecular biology from Kings College, University of Cambridge and his M.D. All proxy statements are public filings made available to the general public by the SEC. Robert Vitti, MD Vice President, Clinical Sciences Ophthalmology Alyson Berliner, MD, PhD Executive Director, Ophthalmology October 11, 2019 Robert (Bob) Vitti and Alyson Berliner sit down to discuss their motivations for studying diabetic retinopathy (DR) and how their job was to shift the mindset around the disease. Onze Before this, Dr. Reinertsen served as the vice president of corporate development at Vertex Pharmaceuticals. Base. Previously, he worked at Pfizer for 10 years focusing on research and early development of biologics, and before that he worked at Rinat Neuroscience Corporation after completing his postdoctoral fellowship at Genentech. David Snow joined Regeneron in 2020 and is senior vice president and global head of the Dupixent(dupilumab) franchise. The estimated total pay for a Vice President at Regeneron is $419,353 per year. envie um e-mail para He previously held various leadership positions in the biopharmaceutical and pharmaceutical industries, including at Merck & Co., Inc., Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated. Toggle navigation Demo Home For YouPersonal Menu For EmployersBusiness Menu Survey CatalogServey Menu degree from New York University. Randy Soltys, Ph.D., joined Regeneron in 2011 and now serves as senior vice president, drug safety and pharmacometrics, where he is responsible for the toxicology, pathology, preclinical PK/PD and clinicaland quantitative pharmacology organizations. The estimated hourly pay at Regeneron ranges from approximately $13.69 per hour for Software Engineer to $71.96 per hour for IT Manager.. Browse 100 estimated salaries at Regeneron in the United States Stocks. As Executive Vice President, Research at REGENERON PHARMACEUTICALS, INC., Andrew J. Murphy Ph.D. made $7,146,830 in total compensation. Dr. DiCioccio earned an B.S. Prior to joining Regeneron, Dr. Murphy worked for seven years at Cadus Pharmaceuticals. REGENERON PHARMACEUTICALS, INC. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Regental Professor and Chairman, Department of Molecular Genetics, The University of Texas Southwestern Center at Dallas. He received his B.A. in biology from the University of Massachusetts. He earned his MBA with the UK Open University and holds a degree in electrical engineering. Ron Wang, Ph.D., joined Regeneron in 1999 andcurrentlyserves as senior vice president of quality control, leading a global functionthat leveragesstrategic business partnerships and automation to provide back-up lab capabilities,protect the supply chain and optimize resources and lab capacity. He is a primary architect of Regenerons cancer immunotherapy program. Based in Tarrytown, New York, with an increasing global footprint, we focus on medicines that meet unmet. Abbott Christina holds an MBA in finance and strategy from the Stern School of Business at New York University and a B.A. Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. Prior to joining Regeneron, Dr. Zambrowicz held roles of increasing responsibility from 1996 to 2015 at Lexicon Pharmaceuticals, Inc., ultimately serving as executive vice president and chief scientific officer. David Simon has been with Regeneron since 1998 and is the senior vice president of industrial operations and product supply (IOPS) finance & business operations. Gregory Geba, M.D., Ph.D., joined Regeneron in 2013 and serves as senior vice president of the global development scientific council, a group that provides senior scientific input to Regenerons therapeutic portfolio of programs. Thomas DiCioccio, Ph.D., joined Regeneron in 2010 and serves as senior vice president, pharmacometrics. Dr. Reinertsen started her biotech career at Millennium Pharmaceuticals (now Takeda Oncology) where she held positions of increasing responsibility in business development. Regeneron , This recognition is possible thanks to our dedicated colleagues, cutting-edge work and a culture that promotes limitless possibilities. Prior to joining Regeneron, Mr. Yocum worked within the Chemistry Department at Seattle Pacific University. Made up of our founding scientists, industry experts, Nobel Laureates and members of the National Academy of Sciences, we consistently push the boundaries of scientific excellence and discovery. J&J Dr. Hughes worked for Sunovion Pharmaceuticals, FORUM Pharmaceuticals, and spent 14 years at Pfizer, where she held various roles of increasing responsibility. Christine Childrose joined Regeneron in 2014 and serves as senior vice president, IOPS human resources and HR Operations. She previously held roles at Regeneron in preclinical manufacturing and process development, process sciences and combination products. The average salary for a Vice President is $172,519 per year in United States, which is 59% lower than the average Regeneron salary of $420,792 per year for this job. Dr. Murphy is a co-inventor of several of Regeneron's key technologies, VelociGene and VelocImmune, and continues to lead several technology centers and therapeutic focus areas. Ms. Bermingham and her Washington, DC-based team play a critical role in helping Regeneron shape and maintain its industry-leading reputation among governmental stakeholders. Prior to joining Regeneron, Dr. Macdonald worked for Cadus Pharmaceuticals after completing a post-doctoral fellowship at Columbia University. She received a J.D. Senior Vice President, Strategic Alliances. Highest reported salary offered at Regeneron Pharmaceuticals is $172k. Prior to Merus N.V., he spent a decade at Novartis in various roles of increasing responsibility, ultimately overseeing the clinical strategy for their immuno-oncology portfolio. This report is not for commercial use. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. from the University of Navarra, completed a fellowship in immunology/pulmonary and critical care at Yale University, received an MPH. Prior to joining Regeneron, he worked at Columbia University College of Physicians and Surgeons for 13 years as Assistant and then associate professor of medicine, and at Merck & Co., Inc. for nine years in positions of increasing responsibility in clinical research, regulatory aairs and global human health. Ci in biology from the University of Science and Technology of China and his Ph.D. in cell biology from the University of Washington. Thorough reviews have been conducted to assure this data accurately reflects disclosures. #GlassdoorBPTW, We are excited to share that for the second year in a row, BioSpace has named us a Best Place to Work. Mr. Van Plew received his M.S. Our leadership team possesses deep and diverse industry knowledge, a passion for science and a shared commitment to help transform lives. In addition to leading manufacturing operations in New Yorks capital region, Mr. Yocums sphere of influence extends beyond manufacturing to encompass all aspects of our quality culture. Jennifer McNay, Ph.D., joined Regeneron in 2000 and serves as senior vice president of chemistry, manufacturing and controls (CMC) regulatory sciences and industrial affairs. The estimated salary at Regeneron ranges from approximately $51,662 per year for Human Resources Specialist to $226,077 per year for Director. Merck Regeneron is a leading biotech company whose mission is to turn science into medicine. Senior Vice President, Chief Compliance Officer. Prior to joining Regeneron, Mr. OLeary has worked as an independent consultant and at Pulmatrix, Alkermes, Organogenesis and Merck Serono. Most recently she was VP, global head of DE&I at Zendesk. As Executive Vice President, Finance and Chief Financial Officer at REGENERON PHARMACEUTICALS, INC., Robert E. Landry made $8,298,455 in total compensation. Average Regeneron Vice President of Supply Chain yearly pay in the United States is approximately $251,000, which is 30% above the national average. CA. He co-founded Agios Pharmaceuticals and previously served as a director of Merck and Charles River Laboratories. How much do Regeneron employees make? Average salary for AstraZeneca Human Resources Vice President in Beckton, England: [salary]. He earned his B.S. Before joining Regeneron, he was at Progenics Pharmaceuticals for 19 years. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. She received her B.S. from Duke University. Goldstein and Brown jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. Ms. Pillai has an accomplished global DE&I career spanning life sciences, technology, financial services and media sectors. pour nous faire part du problme. from the University of Rochester and a Ph.D. from State University of New York. Were proud to be named a Glassdoor Best Places to Work 2023 in the U.S. Ms. Tegan received her B.S. He is responsible for protecting Regenerons intellectual property, including by developing and implementing a comprehensive global IP strategy. She was previously at Pfizer where she held the positions of vice president, business operations and analytics, and, prior to that, vice president, strategic alliance and development operations lead. George D. Yancopoulos, MD, PhD Co-Founder, President and Chief Scientific Officer View bio Corporate Leaders Zoran Berkovic Senior Vice President, Financial Planning and Analysis View bio Maya Bermingham Senior Vice President, Public Policy and Government Affairs View bio Christina Chan He is the former chief executive officer and chair of the board of Prudential Financial, Inc. and served as president and chief operating officer of Chase Manhattan Bank from 1990 to 1994. Abbvie Senior Vice President, Quality Control, Raheen. Prior to Regeneron, Dr. Akinlade held medical director roles of increasing seniority at Astellas Pharma and Abbott Laboratories (now AbbVie). Before joining Regeneron, Mr. Underwood worked at Fluor Daniel, the Jacobs Engineering Group and Day Laboratories. Average salaries for Regeneron Vice President Operations: [salary]. Dr. Bak received her B.S., M.S. , Mr. Yocums broad knowledge and expertise in Good Manufacturing Practices (GMP) and processes have contributed to the successful launch of every Regeneron commercial product. $0. in biology from Brown University, M.D. Richard (Rich) ONeal joined Regeneron in 2018 and is the senior vice president of market access. Boyce F. Martin, Jr., Chief Judge Emeritus, U.S. Court of Appeals for the Sixth Circuit. Dr. Kyratsous previously worked at the Howard Hughes Medical Institute and was a postdoctoral fellow at New York University. Hanne Bak, Ph.D., joined Regeneron in 2004 and serves as senior vice president, preclinical manufacturing and process development (PMPD). He also previously served as vice president, global compliance and legal affairs at Avon Products, Inc., and held a number of senior legal positions at Schering-Plough Corporation, where he was a corporate officer and served as vice president, legal affairs, and a member of the operations management Team. $20.9K. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. She is a former member of the supervisory board of Royal Philips Electronics and the board of directors of Decibel Therapeutics, Inc. David Weinreich, M.D., joined Regeneron in 2016 and serves as executive vice president, global clinical development. Regeneron Pharmaceuticals: Delivering Life-transforming Medicines Push the bounds of science Make life-changing medicines Pause Regeneron News: Feb 23rd Aflibercept 8 mg BLA for Treatment of Wet Age-Related Macular Degeneration and Diabetic Macular Edema Accepted for FDA Priority Review Follow us: Now approved for a new indication Now approved for in international relations and Chinese from Tufts University. She earned a B.S. from Columbia University Law School, where he was a Harlan Fisk Stone Scholar, and his Ph.D. from the Integrated Program in Cellular, Molecular and Biophysical Studies at the Columbia University Graduate School of Arts and Sciences, where he received the Richard C. Parker Award for Outstanding and Innovative Research and a minority pre-doctoral fellowship award. Know Your Worth. om ons te informeren over dit probleem. in biochemical sciences from Princeton University and his M.D., Ph.D. in biochemistry and molecular biophysics from Columbia University. Prior to joining Regeneron, Ms. Ravetti spent 10 years at Pfizer in various positions of increasing responsibility, and she was previously an Associate at the law firm of Sullivan and Cromwell. in biochemistry and cell biology from the University of California, San Diego, and his M.D. The base salary for Vice President of Laboratory in companies like REGENERON PHARMACEUTICALS, INC. range from $271,190 to $329,890 with the average base salary of $295,590. Based on 1 salaries posted anonymously by IPSEN Vice President Human Resources employees in Wherstead, England. He earned his B.S. Senior Vice President, Corporate Communications and Citizenship. He has held leadership positions of increasing responsibility in quality, regulatory affairs, program management and manufacturing across biological, small molecule and medical device platforms. in molecular biology and A.B. Senior Vice President, Early Clinical Development and Experimental Sciences. , years of experience working across multiple relevant functions such as Data Science and Computation, systems engineering, high throughput laboratory automation, research biology, and/or drug ZipRecruiter ATS Jobs for ZipSearch/ZipAlerts - 36 days ago, Addison Group - Los Angeles Aris Baras, M.D., joined Regeneron in 2011 and helped found the Regeneron Genetics Center (RGC), where he now serves as senior vice president. The lowest-paying job at Regeneron is a Research Assistant with a salary of $52,103 per year. message, contactez-nous l'adresse The pharmacometric functions are also responsible for the associated documentation needed to support clinical protocols, as well as the nonclinical PK and clinical pharmacology summaries for the global regulatory filings. This recognition is possible thanks to our dedicated colleagues, cutting-edge work and a culture that promotes limitless possibilities. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. GSK He has been a professor of molecular genetics and internal medicine and the chair of the Department of Molecular Genetics at the University of Texas Southwestern Medical Center at Dallas since 1977. The average Regeneron hourly pay ranges from approximately $24 per hour for an Intern - Hourly to $148 per hour for a Director. Bola Akinlade, M.D., FACP, joined Regeneron in 2015 and serves as senior vice president, clinical development for Regenerons immunology and inflammation (I&I) portfolio. Average salary for AstraZeneca Vice President Finance in Burton Latimer, England: [salary]. from the United States Air Force Academy and her M.A. Our company is built on breakthrough ideas; which is why we foster a spirit of.css-epvm6{white-space:nowrap;} More, Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Anyone wants to share the salary range for VP at the pharma and biotech? Dr. Hirshberg completed his undergraduate and medical degrees at the Hebrew University and is board certified in internal medicine, following his residency at the Hadassah Medical center in Jerusalem. Before joining Regeneron, Dr. Hirshberg was executive vice president, chief medical officer and head of global development at BOL Pharma, a biotech developing medical cannabis therapeutics, where he directed preclinical and clinical development, regulatory, pharmacovigilance and medical affairs. per informarci del problema. He received his B.S. Salary.com's CompAnalyst platform offers: These charts show the average base salary (core compensation), as well as the average total cash compensation for Vice President of Laboratory in companies like REGENERON PHARMACEUTICALS, INC. in the United States. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex,. Executive Vice President, Functional Genomics and Chief VelociGene Operations. Amgen Amgen Former Executive-in-Residence in the Department of Management and Human Resources at the Max M. Fisher College of Business, The Ohio State University. Well-versed in leave administration The VP you'll be reporting to has a collaborative leadershipof Monday, February 13th. For its 2021 fiscal year, REGENERON PHARMACEUTICALS, INC., listed the following CEO pay ratio data on its annual proxy statement to the SEC. She is a former executive-in-residence in the Department of Management and Human Resources and former dean and John W. Berry, Sr. at New York Medical College and a Ph.D. from Saint Johns University. Based on 12 salaries posted anonymously by AstraZeneca Vice President Finance employees in Cannock, England. Based on 12 salaries posted anonymously by AstraZeneca Vice President Finance employees in Burton Latimer, England. Amgen aims to make the most of Amjevita's head start amid broader biosim lull, Lumakras miss. Average salary for AstraZeneca Vice President Finance in Seaham, England: [salary]. in chemical engineering from the University of Nevada, Reno and his Ph.D. in chemical engineering from Iowa State University. Previously, he served in roles of increasing responsibility at Merck, most recently as the vice president and head, early stage development. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. He has prior experiencein healthcare industry-focused venture capital and investment banking roles,as well as serving as an audit seniorat KPMG. Gary Herman, M.D., joined Regeneron in 2015 and leads the early clinical development and experimental sciences (ECDES) function. Lamentamos pelo inconveniente. Wir entschuldigen uns fr die Umstnde. Average salaries for Regeneron Vice President: [salary]. Earlier in her career, Ms. Paull served in progressively senior human resources roles at DENYSPLY International. Read what they think about their salaries on our Compensation FAQ page for , Get started with your Free Employer Profile, Research Associate salaries - 187 salaries reported, Biotech Production Specialist salaries - 169 salaries reported, Scientist salaries - 119 salaries reported, Intern - Hourly salaries - 79 salaries reported, Staff Scientist salaries - 52 salaries reported, Research Associate III salaries - 52 salaries reported, Research Associate II salaries - 48 salaries reported, Associate Director salaries - 45 salaries reported, Senior Manager salaries - 43 salaries reported, R&D Associate salaries - 32 salaries reported, Biotech Production Specialist II salaries - 31 salaries reported, Associate Manager salaries - 31 salaries reported, R&D Specialist salaries - 30 salaries reported, Associate Biotech Production Specialist salaries - 28 salaries reported, Postdoctoral Fellow salaries - 28 salaries reported, QC Analyst salaries - 28 salaries reported, Process Development Engineer salaries - 27 salaries reported. Overall Benefits Rating.css-11cfy92{color:#0caa41 !important;}.css-11cfy92{color:#0caa41 !important;}4.1, Matches half of your contribution up to 5% (of gross pay) on 10%. in chemical engineering at the University of North Dakota, and his Ph.D. in biochemical engineering from Massachusetts Institute of Technology. from Colorado State University. Executive Vice President, General Counsel and Secretary. CA. Sing has been a director of the company since 1988. Senior Vice President, Drug Safety and Pharmacometrics. Mr. McCowan previously worked at international organizations including Amgen, Artemis International, Computer Science Corporation and Lockheed. from Boston College and a B.A. Dr. Bassler has been a director of the company since 2016. and Ph.D. in chemical engineering from the University of Virginia. The lowest-paying job at Regeneron is a Research Assistant with a salary of $52,103 per year. He completed his medical residency at North Shore Long Island Jewish (LIJ) Health System and conducted post doctorate work at Columbia University. He received his B.S. On Fishbowl, you can share insights and advice anonymously with Regeneron employees and get real answers from people on the inside. L. Andres Sirulnik, M.D., Ph.D. joined Regeneron in 2020 and serves as senior vice president, translational & clinical sciences, hematology, leading strategic program direction and clinical sciences work for our early- and late-stage oncologic hematology and late-stage non-oncology hematology portfolios. Our company is built on breakthrough ideas; which is why we foster a spirit of.css-epvm6{white-space:nowrap;}.css-epvm6{white-space:nowrap;} More, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips, A Guide to Negotiating the Salary You Deserve, How to Prepare for Your Interview and Land the Job. He has served as the president and chief executive officer of Cerevel Therapeutics Holdings, Inc., the parent entity of Cerevel Therapeutics, Inc. since 2019, and as chair of Cerevel Therapeutics Holdings, Inc. since 2018. William Olson, Ph.D., joined Regeneron in 2013 as vice president and now serves as senior vice president of therapeutic proteins, where he is responsible for antibody generation, a key component of drug discovery, through innovative technologies. The base salary for Vice President of Laboratory in companies like REGENERON PHARMACEUTICALS, INC. range from $240,390 to $292,490 with the average base salary of $262,090. | Regeneron's CEO, Leonard Schleifer, M.D., Ph.D., collected a . Collectively, through integration of pharmacology with modeling and other quantitative methods, the functions within pharmacometrics play a central role in dose selection from first-in-human studies through global market applications as well as post-approval activities. During her tenure, Dr. Morton has established cardiovascular, renal and fibrosis research at Regeneron. Before that, Dr. Weinreich held positions of increasing responsibility focused on the development of oncology molecules at Amgen. Dr. Yancopoulos joined Dr. Schleifer in 1989 as founding scientist of the company, and together they built and have managed the company since then. Prior to joining Regeneron, Mr. Calabro spent 18 years at UST, Inc., where he held positions of increasing responsibility within internal audit, ultimately serving as director of internal. from Virginia Polytechnic Institute and State University. Mr. Brooks received both a B.S. Bari Kowal joined Regeneron in 2015 and became head of global clinical operations in 2017. The highest-paying job at Regeneron is a Senior Director with a salary of $376,244 per year. Mr. Fenimore is a Certified Public Accountant in the state of New York. Senior Vice President, Manufacturing Operations. Dr. Weinreich also previously served as vice president of clinical affairs at Gene Logic and as an independent consultant, helping small- to mid-stage biotechnology companies with drug commercialization. Aydanos a proteger Glassdoor y demustranos que eres una persona real. . Christos Kyratsous, Ph.D., joined Regeneron in 2011 and is the senior vice president of research. Were proud to be named a Glassdoor Best Places to Work 2023 in the U.S. in neuroscience from New York University. Copyright 2023 Regeneron Pharmaceuticals Inc. All rights reserved. Prior to joining Regeneron, Dr. Stahl received his B.S. Senior Vice President, Global Development Quality & Regulatory Compliance. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. Chairman of the Board; Retired Chairman of the Board and Chief Executive Officer, Merck & Co., Inc. Dr. Vagelos has been chair of the board since January 1995. Si vous continuez voir ce The VP of Product Management will work closely with the engineering, sales, marketing, and production teams leading the product development timelines up until the point of product launch while Scion Executive Search - San Rafael